These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27067282)
1. Hemorrhoids screening and treatment prior to LVAD: is it a necessity? Skouri H; Shurrab M; Zahnan J; Deeba S; Sfeir P; Gharzuddin W; Haj-Yahia S J Cardiothorac Surg; 2016 Apr; 11(1):58. PubMed ID: 27067282 [TBL] [Abstract][Full Text] [Related]
2. Hematologic effects of continuous flow left ventricular assist devices. Slaughter MS J Cardiovasc Transl Res; 2010 Dec; 3(6):618-24. PubMed ID: 20835786 [TBL] [Abstract][Full Text] [Related]
3. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device. Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal bleeding with continuous-flow left ventricular assist devices. Amer S; Shah P; Hassan S Clin J Gastroenterol; 2015 Apr; 8(2):63-7. PubMed ID: 25614135 [TBL] [Abstract][Full Text] [Related]
5. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management. Bartoli CR; Kang J; Motomura T J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785 [TBL] [Abstract][Full Text] [Related]
6. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients. Gurvits GE; Fradkov E World J Gastroenterol; 2017 Jun; 23(22):3945-3953. PubMed ID: 28652649 [TBL] [Abstract][Full Text] [Related]
7. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis. Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363 [TBL] [Abstract][Full Text] [Related]
8. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation. Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377 [TBL] [Abstract][Full Text] [Related]